Innovation Hall Seminar &Happy Hour: Transforming Neurological Disease Modeling with SYN46™ and AI/ML
June 5 | 5:30–6:30 PM | Innovation Hall
Join us for a special happy hour event exploring how cutting-edge synthetic data and AI/ML are transforming neurological disease research.
Dr. Jennifer Fessler, Director of Bioinformatics at General Genomics, Inc., will share how their platform, SYN46™, is enabling breakthroughs in the study of Alzheimer’s, glioma, stroke, TBI, and more!
Enjoy drinks, networking, and a glimpse into the future of brain health innovation.